Huntsman
Texas
Pharmaceuticals Biotechnology and Life Sciences
Corporate Bias Rating
Expand Summary
Risk Level:
Lower Risk
Summary:
Huntsman does not yield to political activism in shaping corporate governance, preventing initiatives that potentially alienate consumers, divide employees, and harm shareholders. The company elevates merit, excellence, and integrity ahead of race and identity-based policies. Huntsman does not embrace corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach protects free exercise, free speech, and free enterprise.
View Full Corporate Bias Ratings ReportShareholder Proposals
Expand Summary
| Date | ESG Category | Proponent | Summary of Resolution | Mgmt Rec | Total Vote % in Favor |
|---|---|---|---|---|---|
| 5/2/24 | Governance | John Chevedden | Transparency in Political Spending | Against | 36.63% |
| 4/21/23 | Governance | John Chevedden | Shareholder Ratification of Excessive Termination Pay | Against | 5.00% |
| 3/25/22 | Governance | John Chevedden | Special Meetings - Reduce Ownership Req. to 10% | Against | 33.92% |
In the News
Expand Summary
Washington Examiner
United Airlines Holdings , American Airlines Group , Boeing , Anheuser-Busch InBev (AB InBev) , Target , American Express (AmEx) , Hyundai , Microsoft , Netflix , Sony , X (Twitter) , Activision Blizzard , Huntsman , Delta Air Lines , Atlassian , Aflac , Tesla , Qualcomm , ABB , Duke Energy
United Airlines Holdings , American Airlines Group , Boeing , Anheuser-Busch InBev (AB InBev) , Target , American Express (AmEx) , Hyundai , Microsoft , Netflix , Sony , X (Twitter) , Activision Blizzard , Huntsman , Delta Air Lines , Atlassian , Aflac , Tesla , Qualcomm , ABB , Duke Energy